Women in Science

Launched in 2019, the Women in Science Translational Research Symposia were created to clarify the most targeted route to commercialization for female scientists and help advance their discoveries to market. The program is committed to addressing the gender gap in innovation and changing this paradigm through knowledge and network creation.

Operations Team

New and growing enterprises face the challenge of simultaneously executing complex business strategies, building world-class operating teams, creating partnerships, and a wide range of other critical functions with limited resources. The Deerfield Operations team partners with newly formed, and existing management teams, providing a suite of services designed to enhance company success and growth while reducing timelines to value-creating events and overall costs.  While many companies require significant support early in the life cycle, the Operations team is structured in a manner that allows Deerfield to be a long-term partner, offering services and assistance to businesses across all stages of maturity, from formation to a successful monetization event.

Services provided by the Deerfield Operations team, include:

  • Human Resources and Talent Acquisition
  • Accounting and Financial Management
  • Real Estate Sourcing and Negotiation
  • Risk Management
  • Information Technology
  • Sales, Marketing and Other Commercial Support
  • Business Strategy and Development
  • Contracting Support
  • Marketing/Branding/Public Relations
  • Investor Relations

Fellowships

Beginning in 2015, Deerfield started the Deerfield Fellows program, designed to attract students with interest in pursuing healthcare or finance fields from local NYC-area colleges and universities from diverse backgrounds for an immersive summer internship program. Successful summer interns are invited to stay through a yearlong Deerfield Fellowship program, with the most successful of those graduating to become Associates at Deerfield. We are extremely proud of the work our Associates do.

About Deerfield

Advancing healthcare® through investment, information, and philanthropy.

Launched in 1994, Deerfield Management Company is an investment firm dedicated to advancing healthcare through information, investment, and philanthropy—all toward the end goal of cures for disease, improved quality of life, and reduced cost of care. As of December 2020, the firm manages more than $13 billion in assets.

Providing value beyond capital, Deerfield generally maintains a combined portfolio of more than 200 private and public investments across the life science, medical device, diagnostic, digital health and health service industries at all stages of evolution from start-up to mature company.

Having many years of operational expertise, Deerfielders are highly engaged and adept at navigating the complex crosscurrents ever-present in the healthcare and financial industries.

Collaboration, intellectual curiosity and pragmatism drive Deerfield’s approach. With its holistic view, Deerfield tailors flexible financing options designed to meet the needs of entrepreneurs and corporate partners.

Deerfield Investment
Supporting companies across the healthcare ecosystem with flexible funding models and value beyond capital.
Deerfield Institute
Delivering market research to the Deerfield team, its portfolio companies and other partners.
Deerfield Foundation
A New York City-based not-for-profit devoted to advancing innovative health care initiatives.

Value beyond capital

Pioneering a model of partnership with academic institutions which creates the potential for rapid funding and advancement of promising therapies. Learn more

Partnering with leading academic research centers to further sustain and accelerate the commercialization of discoveries toward meaningful societal impact by advancing cures for disease. Learn more

The Deerfield Operations team partners with newly formed, and existing management teams, providing a suite of services designed to enhance company success and growth while reducing timelines to value-creating events and overall costs. Learn more

Programs

Deerfield and Oxeon founded the Break into the Boardroom program (BiB) based on a shared belief that their organizations are uniquely positioned to not only cultivate new female board candidates but to also connect these women with concrete governance opportunities.
Learn more

Launched in 2019, the Women in Science Translational Research Symposia were created to clarify the most targeted route to commercialization for female scientists and help advance their discoveries to market. The program is committed to addressing the gender gap in innovation and changing this paradigm through knowledge and network creation.

Beginning in 2015, Deerfield started the Deerfield Fellows program, designed to attract students with interest in pursuing healthcare or finance fields from local NYC-area colleges and universities from diverse backgrounds for an immersive summer internship program. Successful summer interns are invited to stay through a yearlong Deerfield Fellowship program, with the most successful of those graduating to become Associates at Deerfield. We are extremely proud of the work our Associates do.
Meet the Fellows’ Alumni
CURE.
At CURE. — Deerfield’s innovation campus on 345 Park Avenue South — we’re transforming healthcare. Here, innovators from across the industry and around the world work shoulder to shoulder to develop treatments to eliminate deadly diseases and create new healthcare delivery models to lower cost and improve care for those in need.
Discover our mission

Deerfield Institute

Established in 2006, the Deerfield Institute delivers sophisticated and timely market research, which enhances the insights available to the investment team and its partners. The Institute develops and analyzes data to advance understanding of innovations and emerging products, and it also informs on trends within the healthcare market. It has published important scientific findings in peer-reviewed journals to extend learnings to the scientific community and benefit public health at large—and  ultimately patients in need. The Institute is guided by Deerfield’s core values: integrity, the pursuit of objective and unbiased research, commitment to excellence, precision and accuracy.

Deerfield Institute Capabilities: 

PUBLICATIONS
We publish research data to help advance healthcare and to enable researchers to have access to recent, relevant information.
View latest publications

Confidentiality

Deerfield Institute believes that market research is a valuable resource to the growing healthcare industry. A critical component of this research is assuring respondents that their information is being used properly and within standard industry guidelines. Individual responses from any market research effort are kept confidential and are reported without individual identifying information. During our research process, we collect, aggregate, and analyze information from respondents in various healthcare-related fields. We then prepare reports based on these answers for the purposes of understanding market level dynamics.

When participating in Deerfield Institute market research, respondents may be asked to provide personally identifiable information (such as name, email, and mailing address). This information will only be used to provide respondents with services or information that they have requested. When preparing reports or analyzing the results of our market research, personally identifiable information is always removed and will not be given or sold to a third party without the respondent’s consent.

All Deerfield Institute research is conducted in compliance with the Health Insurance Portability and Accountability Act (HIPAA).

As part of our research process we seek the insight of key opinion leaders and other expert advisors in the healthcare field. Our compliance framework is designed to avoid the receipt by Deerfield Institute of confidential information and strict policies and procedures must be followed in the engagement of these advisors. All paid advisors are required to sign terms and conditions that clearly define their responsibility to not disclose information to which they have a duty of confidence.

All Deerfield participants in an advisor interaction are trained in our compliance procedures and are required to give compliance reminders to expert consultants prior to each interaction. These policies and procedures extend to all of our partners that facilitate access to our advisors.

Deerfield Foundation

An affiliate of Deerfield Management, the Deerfield Foundation is a New York City-based not-for-profit devoted to advancing innovative health care initiatives. Since 2007, the Foundation has formed 56 partnerships and invested in the advancement of children’s health, from clinics in the South Bronx to Nepal. Funds are provided through employee contributions and directly from Deerfield’s profits. With these anticipated funds, the Foundation will have resources to fund the development and availability of therapeutics in areas in which philanthropic funding is needed to expand patient treatment options.

Executive Committee

CHAIRMAN: Alexis Cazé

PRESIDENT: Andrew ElBardissi, MD

VICE PRESIDENTS

TREASURER: Kerri Seacord

SECRETARY: Kathryn Wilson 

Academic Collaborations

Deerfield Management recognizes that investigators at academic research institutions provide much of the novel insights that advance our understanding of disease. However, at any research institution, the most commercially promising innovations eventually outgrow the lab, requiring greater resources and more focused development expertise than an academic setting can typically provide.

To bridge that gap, Deerfield partners with leading academic research centers from across the country, providing critical funding and expertise to further sustain and accelerate the commercialization of discoveries toward meaningful societal impact by advancing cures for disease.

Together with its academic partners, Deerfield has created 16 spin-off companies to date that are supporting key avenues from concept to spin-out of novel therapeutic discoveries, as well as an incubator focused on innovative cardiovascular devices.

Deerfield’s 16 academic partnerships, involving 18 institutions, include Boston Children’s Hospital, University of Michigan, Yeda Research and Development Co. Ltd., the commercial arm of the Weizmann Institute of Science; Duke University; Columbia University; Northwestern; Harvard; Vanderbilt; Johns Hopkins; Dana Farber; the Broad Institute; University of North Carolina-Chapel Hill; University of California-San Diego; and the University of Illinois at Chicago. Deerfield also has a combined association with Rockefeller University, Cornell, and Memorial Sloan Kettering Cancer Center through their joint discovery unit, the TDI. Finally, Deerfield has a project-specific collaboration with MD Anderson Cancer Center.

Far beyond its financial resources—with its long vision, operational expertise, and command in the life science and healthcare space for more than two decades, Deerfield is uniquely positioned to support all stages of development from early-stage to market—advancing science and enabling the translation of ideas into medicines.

Deerfield Discovery and Development (3DC)

Researchers at academic institutions discover many of the novel insights that advance our understanding of disease. Commercially promising innovations eventually outgrow the lab, requiring greater resources and more focused development expertise than an academic setting can typically provide. To address this need, Deerfield has pioneered a model of partnership with academic institutions, which creates the potential for rapid funding and advancement of promising therapies. Partner institutions today include: Yeda, the commercial arm of the Weizmann Institute of Science; Duke University; Columbia University; Northwestern; Harvard; Vanderbilt; Johns Hopkins; Dana Farber; the Broad Institute; University of North Carolina-Chapel Hill; University of California-San Diego; and the University of Illinois at Chicago. In addition, Deerfield has a combined association with Rockefeller University, Cornell and Memorial Sloan Kettering Cancer Center through their joint discovery unit, the TDI; and, finally, Deerfield has a project-specific collaboration with MD Anderson Cancer Center.

Deerfield Discovery and Development (3DC) plays a critical role in progressing early-stage therapeutics from scientific discovery through preclinical proof of concept and into the clinic, via design and execution of relevant experiments. 3DC partners closely with principal investigators in Deerfield’s academic collaboration network, corporate partners and entrepreneurs to provide deep functional expertise and experience across key disciplines. These include:

Break into the Boardroom

Despite the high aptitude of this representative sample of female leaders, the stark reality is boards are only made up of 20% women. Deerfield and Oxeon founded the Break into the Boardroom program (BiB) based on a shared belief that their organizations are uniquely positioned to not only cultivate new female board candidates but to also connect these women with concrete governance opportunities.

Deerfield and Oxeon focus on identifying talent, building companies, and deploying capital within the healthcare ecosystem, which enables BiB to create the perfect intersection of supply and demand. This framework naturally mitigates the classic chicken and egg problem that has proven such an intractable obstacle to the goal of increasing female board representation.

Please visit our website where you may submit inquiries regarding potential board roles or nominate a female executive from your organization to participate in our program.

Funding models

Deerfield tailors flexible financing options designed to meet the needs of its corporate partners most optimally. Some of our funding options include: